ascendis pharma glp-1 receptor agonist Novo Nordisk taps in $285 million deal Novo Nordisk signs $285m deal
Pay in 4 interest-free payments of $5.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4






























